TY - JOUR
T1 - The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt
AU - Rabie, Rania Nancy
AU - Cazzaniga, Massimo
AU - Salerno, Francesco
AU - Wong, Florence
PY - 2009/10
Y1 - 2009/10
N2 - OBJECTIVES:The clinical significance of diastolic dysfunction in cirrhosis, a feature of cirrhotic cardiomyopathy, is unclear. The aim of this study was to assess the utility of E/A ratio, an indicator of diastolic dysfunction, to predict ascites clearance and mortality after transjugular intrahepatic portosystemic stent shunt (TIPS) insertion.METHODS:A total of 101 cirrhotic patients who received TIPS had pre-TIPS assessments of demographics, severity of liver dysfunction (Child-Pugh and Model for End-Stage Liver Disease (MELD) scores), renal function, hemodynamics, and cardiac function (two-dimensional echocardiography). An E/A ratio of 1 was used to indicate diastolic dysfunction. Patients were followed-up for a mean period of 24.62.4 months post TIPS.RESULTS:A total of 41 patients with an E/A ratio of 1 (group A), and 60 patients with an E/A ratio of 1 (group B) were studied. Group A had significantly higher MELD scores (14.01.0 vs. 11.40.8; P0.03), because of higher serum creatinine levels (1075 vs. 866 mol/l; P0.01). There was no difference in pre-TIPS systemic hemodynamics, systolic function, or portal pressure between the two groups. After TIPS, more patients in group B had ascites clearance (log rank, P0.038), and the same patients had a higher probability of survival (log rank, P0.046). There were three post-TIPS cardiac deaths in group A only. A multivariate analysis showed that an E/A of ratio 1 was predictive of slow ascites clearance (hazard ratio7.3, 95% confidence interval1.3-40.7, P0.021) and death after TIPS (hazard ratio4.7, 95% confidence interval1.1-20.2, P0.035).CONCLUSIONS:Diastolic dysfunction, indicated by reduced E/A ratio, is prevalent in advanced cirrhosis and is associated with reduced ascites clearance and increased mortality post TIPS, possibly related to worsening of hemodynamic dysfunction in the post-TIPS period.
AB - OBJECTIVES:The clinical significance of diastolic dysfunction in cirrhosis, a feature of cirrhotic cardiomyopathy, is unclear. The aim of this study was to assess the utility of E/A ratio, an indicator of diastolic dysfunction, to predict ascites clearance and mortality after transjugular intrahepatic portosystemic stent shunt (TIPS) insertion.METHODS:A total of 101 cirrhotic patients who received TIPS had pre-TIPS assessments of demographics, severity of liver dysfunction (Child-Pugh and Model for End-Stage Liver Disease (MELD) scores), renal function, hemodynamics, and cardiac function (two-dimensional echocardiography). An E/A ratio of 1 was used to indicate diastolic dysfunction. Patients were followed-up for a mean period of 24.62.4 months post TIPS.RESULTS:A total of 41 patients with an E/A ratio of 1 (group A), and 60 patients with an E/A ratio of 1 (group B) were studied. Group A had significantly higher MELD scores (14.01.0 vs. 11.40.8; P0.03), because of higher serum creatinine levels (1075 vs. 866 mol/l; P0.01). There was no difference in pre-TIPS systemic hemodynamics, systolic function, or portal pressure between the two groups. After TIPS, more patients in group B had ascites clearance (log rank, P0.038), and the same patients had a higher probability of survival (log rank, P0.046). There were three post-TIPS cardiac deaths in group A only. A multivariate analysis showed that an E/A of ratio 1 was predictive of slow ascites clearance (hazard ratio7.3, 95% confidence interval1.3-40.7, P0.021) and death after TIPS (hazard ratio4.7, 95% confidence interval1.1-20.2, P0.035).CONCLUSIONS:Diastolic dysfunction, indicated by reduced E/A ratio, is prevalent in advanced cirrhosis and is associated with reduced ascites clearance and increased mortality post TIPS, possibly related to worsening of hemodynamic dysfunction in the post-TIPS period.
UR - http://www.scopus.com/inward/record.url?scp=70349693457&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70349693457&partnerID=8YFLogxK
U2 - 10.1038/ajg.2009.321
DO - 10.1038/ajg.2009.321
M3 - Article
C2 - 19532126
AN - SCOPUS:70349693457
VL - 104
SP - 2458
EP - 2466
JO - American Journal of Gastroenterology
JF - American Journal of Gastroenterology
SN - 0002-9270
IS - 10
ER -